Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

KIAA1429/VIRMA promotes breast cancer progression by m6A‐dependent cytosolic HAS2 stabilization

EMBO Reports(2023)10.15252/embr.202255506Source: DataRank Database

KIAA1429/VIRMA promotes breast cancer progression by m6A‐dependent cytosolic HAS2 stabilization is a research paper published in EMBO Reports (2023). On theSindex it has a DataRank of 0.889. It has been cited 29 times, with 26 citing works in its 1-hop citation network.

N/A

0.889DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access29 citations · 26 citing works in its network

Download PDF

Cite:

Linked data & code

Data availability

Repositories this paper deposited data in (declared in PubMed).

GEOGSE185494

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 2.69)OA: hybridTopics (30)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 57%Citation Network 43%

Base Score Contribution

0.510

From this paper's citation signal

Citation Network Contribution

0.379

From 17 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 26 citers.

KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner
Journal of Translational Medicine202419 citations48 referencesContributes 0.062
N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy
Biomolecules202414 citations51 referencesContributes 0.053
Phosphorylation of KIAA1429 promotes oxaliplatin resistance through activating the FZD7-Wnt signaling in BRAFV600E-mutated colorectal cancer
Journal of Experimental & Clinical Cancer Research20253 citations31 referencesContributes 0.045
Mechanism of the KIAA1429/KLF1/PD-L1 Axis in Regulating Immune Escape in Non-small Cell Lung Cancer
Cell Biochemistry and Biophysics20244 citations41 referencesContributes 0.039
VIRMA-Mediated the m6A Methylation of SCD Facilitates Wilms’ Tumor Progression via AMPK Pathway
DNA and Cell Biology20253 citations39 referencesContributes 0.036

Authors (7)

Zhouting Zhu ORCID,Yufei Deng ORCID,R. Tang ORCID,Hui Hui ORCID,Yuqi Kang ORCID

Live enrichment

PubMed:37705505 PMC:PMC10561361 OpenAlex:https://openalex.org/W4386725474

HHS ¦ NIH ¦ National Cancer Institute

Grant: CA177322

HHS ¦ NIH ¦ National Cancer Institute

Grant: CA030199

HHS ¦ NIH ¦ National Institute of Allergy and Infectious Diseases

Grant: AI125103

HHS ¦ NIH ¦ National Institute on Drug Abuse

Grant: DA046171

National Institutes of Health SIG

Grant: S10 OD026929

NIDA NIH HHS

Grant: R01 DA046171

NCI NIH HHS

Grant: P30 CA030199

NIAID NIH HHS

Grant: R21 AI125103

NCI NIH HHS

Grant: P01 CA177322

National Institutes of Health

Grant: 1R01DA046171-01

Identification and Regulation of RNA Modification by HIV infection and Methamphetamine

National Institutes of Health

Grant: 1R21AI125103-01A1

Regulation of HIV-1 Replication by Cellular IncRNAs

National Institutes of Health

Grant: 1S10OD026929-01

Illumina NovaSeq 6000 Sequencing System

National Institutes of Health

Grant: 5P01CA177322-03

Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses

National Institutes of Health

Grant: 5P30CA030199-37

Cancer Center Support Grant (CCSG)

FWCI

2.69

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.15252/embr.202255506

publisherhttps://doi.org/10.15252/embr.202255506

publisherhttps://link.springer.com/content/pdf/10.15252/embr.202255506.pdf

publisherhttps://link.springer.com/article/10.15252/embr.202255506/fulltext.html

publisherhttps://www.embopress.org/doi/pdf/10.15252/embr.202255506

Fields of Study

RNA modifications and cancerCancer-related gene regulationPeptidase Inhibition and Analysis0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Hyaluronan SynthasesCytoplasmCytosolHumansNeoplasmsRNA, Messenger

Keywords

CytosolBreast cancerChemistryCancerBiologyBiochemistryGeneticsEnzymeHas2Igf2bp3Kiaa1429/virmaM6a Rna ModificationCytoplasmNeoplasmsHumansArticlesRNA, MessengerHyaluronan Synthases

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner

10.6084/m9.figshare.26074162.v1figshare

Additional file 1 of KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner

10.6084/m9.figshare.26074162figshare